Results of the Cox regression analysis in 1795 patients who exhibited the 8 parameters having significant influence on overall survival
Variable . | Adverse factor . | P . | RR . | 95% CI . |
|---|---|---|---|---|
| Sex | Male | .001 | 1.33 | 1.14-1.56 |
| Age | > 60 years | < 10-3 | 2.40 | 2.05-2.81 |
| Ann Arbor stage | III-IV | < 10-3 | 1.66 | 1.26-2.19 |
| Bone marrow | Involved | .001 | 1.37 | 1.14-1.64 |
| Number of nodal sites | > 4 | .001 | 1.32 | 1.11-1.56 |
| Hemoglobin level | < 120 g/L | < 10-3 | 1.59 | 1.31-1.92 |
| PB lymphocyte count | < 1 × 109/L | .008 | 1.27 | 1.06-1.52 |
| LDH | > ULN | < 10-3 | 1.50 | 1.26-1.77 |
Variable . | Adverse factor . | P . | RR . | 95% CI . |
|---|---|---|---|---|
| Sex | Male | .001 | 1.33 | 1.14-1.56 |
| Age | > 60 years | < 10-3 | 2.40 | 2.05-2.81 |
| Ann Arbor stage | III-IV | < 10-3 | 1.66 | 1.26-2.19 |
| Bone marrow | Involved | .001 | 1.37 | 1.14-1.64 |
| Number of nodal sites | > 4 | .001 | 1.32 | 1.11-1.56 |
| Hemoglobin level | < 120 g/L | < 10-3 | 1.59 | 1.31-1.92 |
| PB lymphocyte count | < 1 × 109/L | .008 | 1.27 | 1.06-1.52 |
| LDH | > ULN | < 10-3 | 1.50 | 1.26-1.77 |
RR indicates relative risk (of death); CI, confidence interval; PB, peripheral blood; LDH, lactate dehydrogenase; and ULN, upper limit of normal.